15-Year-Old Kenyan Girl With Rare Autoimmune Disease Successfully Treated With Cell-based Therapy-Maharashtra Government Inks MoU with IBM Technology for AI Centers-Governor C. P. Radhakrishnan visits Prime Minister Narendra Modi-AMRIT MAHOTSAV OF SHREE MARKET SILK MERCHANTS ASSOCIATION ENDED ON 14TH APRIL, 2025 WITH ALL ITS GRANDEUR-Agra Startup Jatbat Playmax Media Aims to Entertain and Educate with Diverse Book Selection-Indkal Technologies Cements It's Mumbai Presence through Strategic Partnership with Digi1 Electronics-Shree Market Silk Merchants Association (SMSMA) to Celebrate Completion of Amrut Mahotsav on 14th April-SUPREME COURT TAKES COGNIZANCE OF CHILD SAFETY CONCERNS IN DIGITAL SPACE-TechnoServe and The Solvent Extractors’ Association of India Sign Landmark MoU to Advance Edible Oil Fortification-'Economic Nationalism' to Strengthen Domestic Supply Chains at FICCI’s 98th Foundation Day-Piyush Goyal

#Strides

BUSINESS, Corporate, Finance, HOME, Hospital, Health & Pharma, INDUSTRY, Investment, NATION, NEW PRODUCT LAUNCH, Research & Analysis, STATE July 9, 2020

Strides receives USFDA approval for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules

To be marketed by Strides Pharma Inc. in the US market MUMBAI, JULY 09, 2020 (GPN)- Strides Pharma  Science  Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has…